Showing a trial related to 

Recruiting

Procedure for Lung Cancer, sponsored by Middlemore Hospital, New Zealand

Get in touch This trial recruits from July 2015 for 152 weeks

Samantha Herath, MBBS, MPhil, FRACP

Phone: 0064-211298979

Email: samantha.herath@middlemore.co.nz

Inclusion Criteria

Age: From 18 Years To N/A

Gender: Both

Inclusion Criteria

  • All patients aged >18 years with a peripheral pulmonary lesion, suspected of lung cancer, requiring a biopsy

  • The lesion will be included irrespective of the relationship to the bronchus or ground glass appearance.

Exclusion Criteria

  1. Patients with mediastinal adenopathy amenable to liner EBUS should have this procedure first and enrolled only if it fails to derive a diagnosis.

  2. Endobronchial tumour on flexible bronchoscopy

  3. Platelet count>150

  4. International Normalised Ratio >=1.5

  5. Haemoglobin>100

  6. Neutrophils >1.0

  7. Glomerular Filtration Rate>30

  8. Liver Function Test< 2 times upper limit of normal

  9. Unable to give consent/intellectually impaired

Exclusion Criteria

NCT02395939

Randomised Controlled Trial Comparing the Diagnostic Yield of Radial Endo-Bronchial Ultra-Sound (R-EBUS) Guided Cryo-biopsy Vs. CT-guided Transthoracic Biopsy in Patients With Parenchymal Lung Lesion, Suspected of Lung Cancer (CT-CROP)

Comparing Diagnostic Yield Between R-EBUS Guided Cryo Biopsy Vs. CT Guided Biopsy for PPL

View record on ClinicalTrials.gov